Related Experiment Video
Updated: Jun 5, 2026
04:09
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Treating diabetic ulcers.
Francesco Tecilazich1, Thanh Dinh, Aristidis Veves
1Beth Israel Deaconess Medical Center, Joslin-Beth Israel Deaconess Foot Center and Microcirculation Lab, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Expert Opinion on Pharmacotherapy
|January 19, 2011
Summary
Diabetic foot ulceration, a severe diabetes complication, requires addressing multifactorial causes for effective wound healing. Adhering to standard treatments can prevent lower-extremity amputations.
Area of Science:
- Diabetology
- Wound Healing Research
- Vascular Surgery
Background:
- Diabetic foot ulceration is a significant complication of diabetes mellitus.
- It is a leading cause of hospitalization among diabetic patients.
- The complex, multifactorial etiology necessitates comprehensive management for healing.
Purpose of the Study:
- To review the pathophysiology of diabetic foot ulceration and impaired wound healing.
- To examine current standard treatments and novel therapeutic strategies.
- To provide an understanding of the latest research and established therapies.
Main Methods:
- Literature review focusing on pathophysiology.
- Review of standard and advanced wound care products.
- Exploration of emerging therapeutic approaches.
Main Results:
- Detailed examination of the pathophysiology of diabetic foot ulceration.
- Overview of established and investigational treatment modalities.
- Emphasis on the multifactorial nature of the condition.
Conclusions:
- Diabetic foot ulceration is a serious complication that can lead to amputations.
- Adherence to standard treatment strategies is crucial for preventing amputations.
- Comprehensive management addressing all contributing factors is key to successful wound healing.
Related Concept Videos
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...